US Patent Issued to MABWELL (SHANGHAI) BIOSCIENCE on Aug. 25 for "TGF-beta RII mutant and fusion protein thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,904, issued on Aug. 25, was assigned to MABWELL (SHANGHAI) BIOSCIENCE Co. LTD. (Shanghai).

"TGF-beta RII mutant and fusion protein thereof" was invented by Jinchao Zhang (Shanghai), Shuang Wang (Shanghai), Shasha Jiao (Shanghai), Chang Zhang (Shanghai), Rongjuan Wang (Shanghai) and Dadi Zeng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "In view of the technical problem that TGF-Beta RII and a fusion protein thereof are prone to degradation and breakage during the process of recombinant expression, provided are a TGF-Beta RII mutant and a fusion protein thereof. Compared with the extracellular region of the wild-type TGF-Beta RII of SEQ ID...